|
Melanoma
|
SGC-t
|
200965_s_at (99%), 213050_at (1%)
|
| |
SGC-W
|
217906_at (92%), 218552_at (4%), 218996_at (1%), 219343_at (1%), 221577_x_at (1%), 221882_s_at (1%)
|
|
Breast Cancer 1
|
SGC-t
|
259466 (92%), 291660 (5%), 950574 (3%)
|
| |
SGC-W
|
259466 (98%), 291660 (2%)
|
|
Brain Cancer
|
SGC-t
|
J02611_at (95%), X53331_at (5%)
|
| |
SGC-W
|
J02611_at (93%), X67951_at (3%), HG3543-HT3739_at (2%), X12794_at (2%),
|
|
Breast Cancer 2
|
SGC-t
|
AI868854 (65%), AK026899 (13%), AK026789 (12%), AK025709 (3%), AI240933 (3%), AF119844 (2%), AW006861 (2%)
|
| |
SGC-W
|
N30081 (65%), AF119844 (23%), AI868854 (12%)
|
|
Gastric Tumor
|
SGC-t
|
W70254 (100%)
|
| |
SGC-W
|
AA171606 (94%), W70254 (6%)
|
|
Lung Cancer 1
|
SGC-t
|
37210_at (66%), 198_g_at (15%), 40165_at (12%), 32254_at (5%), 41344_s_at (2%)
|
| |
SGC-W
|
1252_at (100%)
|
|
Lung Cancer 2
|
SGC-t
|
33754_at (100%)
|
| |
SGC-W
|
40936_at (98%), 33833_at (0.5%), 34320_at (0.5%), 37157_at (0.5%), 39640_at (0.5%)
|
|
Lymphoma
|
SGC-t
|
X76538_at (100%)
|
| |
SGC-W
|
X76538_at (91%), D30655_at (9%)
|
|
Myeloma
|
SGC-t
|
33146_at (88%), 32546_at (12%)
|
| |
SGC-W
|
32546_at (99%), 1071_at (1%)
|
|
Pancreatic Cancer
|
SGC-t
|
209596_at (98%), 206451_at (2%)
|
| |
SGC-W
|
206451_at (45%), 209596_at (43%), 218498_s_at (6%), 219625_s_at (4%), 212058_at (2%)
|
|
Prostate Cancer
|
SGC-t
|
34452_at (100%)
|
| |
SGC-W
|
34452_at (100%)
|
